|
Title
|
Credit (Amnt/Type)
|
Est.Time
|
Expires
|
|
nab-Paclitaxel Improves Overall Response Rate, Reduces Neuropathy in Patients with Advanced Non-Small-Cell Lung Cancer Regardless of Histology; Elderly Also Benefit
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.50 hours
|
November 20, 2013
|
|
A Virtual Lecture on Current and Emerging Perspectives in the Diagnosis and Management of Adult Glioblastoma
|
1.25
/
AMA PRA Category 1 Credit(s)TM
1.10
/
CE for Nurses
1.10
/
CE for Pharmacists
|
1.25 hours
|
August 27, 2013
|
|
Abiraterone Acetate plus Prednisone Demonstrates Better Pain Control vs Prednisone Alone in Patients with Metastatic Castration-Resistant Prostate Cancer
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
30 minutes
|
September 06, 2012
|
|
Adjuvant Treatment with Zoledronic Acid Does Not Improve Disease-Free Survival in Stage II/III Breast Cancer
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
30 minutes
|
February 29, 2012
|
|
Adrenal Masses: Often Incidental, Not Always Insignificant
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 hour
|
April 30, 2014
|
|
Advances in BRAF-Targeted Therapy for Melanoma
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.50 hours
|
April 19, 2014
|
|
Advances in the Treatment of Metastatic HER2-Positive Breast Cancer: From Trastuzumab and Beyond
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.50 hours
|
March 25, 2014
|
|
Afatinib 'Clinically Relevant' First-Line Treatment Option for EGFR-Mutation Positive Lung Adenocarcinoma
|
0.50
/
AMA PRA Category 1 Credit(s)TM
|
0.50 hours
|
November 20, 2013
|
|
An Update on Robotic-Assisted Partial Nephrectomy
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 hour
|
January 31, 2013
|
|
Androgen Deprivation Therapy in Prostate Cancer: Addressing Clinical Challenges
|
1.00
/
AMA PRA Category 1 Credit(s)TM
|
1 hour
|
January 04, 2012
|